Clinical Trial Update: Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of topotecan and carboplatin as first-line therapy for extensive-stage small cell lung cancer has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Topotecan (topotecan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Carcinoma, Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2013-01-24